David Rosenfield Selected Research

Cycloserine (Seromycin)

1/2020	Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.
1/2020	Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
12/2019	Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
1/2019	Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder.
1/2017	D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
12/2015	EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER.
7/2015	Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
12/2013	D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.
11/2013	Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
10/2013	D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Rosenfield Research Topics

Disease

9	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2022 - 11/2012
9	Anxiety Disorders (Anxiety Disorder) 11/2021 - 11/2010
9	Social Phobia 01/2020 - 11/2010
7	Asthma (Bronchial Asthma) 01/2022 - 02/2008
7	Panic Disorder (Panic Attack) 01/2020 - 06/2007
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 03/2022 - 05/2013
5	Agoraphobia 01/2015 - 06/2007
3	Substance Withdrawal Syndrome (Withdrawal Symptoms) 09/2020 - 06/2012
3	Inflammation (Inflammations) 01/2019 - 05/2008
3	Tobacco Use Disorder (Nicotine Dependence) 09/2017 - 06/2012
2	Infections 01/2018 - 01/2018
2	Wounds and Injuries (Trauma) 01/2018 - 06/2015
2	Obesity 06/2016 - 11/2010
2	Phobic Disorders (Phobia) 10/2014 - 06/2013
1	Dyspnea (Shortness of Breath) 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Hypoventilation 01/2018
1	Metabolic Diseases (Metabolic Disease) 06/2016
1	Alcoholism (Alcohol Abuse) 01/2016
1	Psychomotor Agitation (Akathisia) 05/2013
1	Anhedonia 05/2013
1	Allergic Rhinitis 01/2013
1	Mania (Manias) 11/2010
1	Major Depressive Disorder (Major Depressive Disorders) 11/2010
1	Mental Disorders (Mental Disorder) 11/2010
1	Mood Disorders (Mood Disorder) 11/2010
1	Hypocapnia 02/2008

Drug/Important Bio-Agent (IBA)

13	Cycloserine (Seromycin)FDA Link 01/2020 - 02/2013
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 05/2008
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2022 - 05/2013
4	Nicotine FDA Link 09/2020 - 06/2012
3	Carbon DioxideIBA 01/2018 - 11/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2013
2	Antidepressive Agents (Antidepressants)IBA 01/2017 - 11/2010
2	Yohimbine (Yocon)IBA 09/2016 - 06/2014
2	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2016 - 11/2015
1	Paroxetine (Paxil)FDA LinkGeneric 01/2022
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2022
1	SmokeIBA 11/2021
1	NitratesIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Varenicline (Chantix)FDA Link 09/2017
1	Naltrexone (ReVia)FDA LinkGeneric 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Nootropic Agents (Nootropics)IBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 06/2015
1	Risperidone (Risperdal Consta)FDA LinkGeneric 04/2015
1	Methacholine Chloride (Methacholine)FDA Link 11/2014
1	Bronchodilator Agents (Bronchodilators)IBA 11/2014
1	Methylene Blue (Methylthioninium Chloride)FDA Link 10/2014
1	D 53IBA 06/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2013
1	Interleukin-4 (Interleukin 4)IBA 01/2013
1	Interferon-gamma (Interferon, gamma)IBA 01/2013
1	Antipsychotic Agents (Antipsychotics)IBA 11/2010
1	Anti-Anxiety Agents (Anxiolytics)IBA 11/2010
1	Hypnotics and Sedatives (Sedatives)IBA 11/2010
1	OzoneIBA 05/2008
1	AllergensIBA 05/2008
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 02/2008

Therapy/Procedure

7	Therapeutics 06/2022 - 10/2012
2	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
1	Surgical Instruments (Clip) 01/2017
1	Cognitive Training 10/2010